Another set of data supporting the safety and accuracy of DexCom’s G7 continuous glucose monitor (CGM) is now published in Diabetes Technology & Therapeutics.
The 10-and-a-half day experiment included 316 participants with both type I and type II diabetes partake in in-clinic visits on...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?